Federal Circuit / U.S. Court of Spec. Jurisdiction

Federal Circuit / U.S. Court of Spec. Jurisdiction
(incl: International Trade (Customs), Federal Claims, Armed Forces, Federal Adm. Agencies & Boards, Immigration, Tax, Gov. Personnel Appeals, Patent , Trademark, Veterans Appeals, etc.)

Custom text Title Organization
Feb
18
2016
 Sandoz Asks Supreme Court To Reverse Biosimilar Decision Foley & Lardner LLP
Aug
25
2016
 The Evolving Standard for Pleading Direct Patent Infringement Foley & Lardner LLP
Sep
21
2016
 Inherent Disclosure Satisfied Written Description Foley & Lardner LLP
Oct
25
2016
 Pharmaceutical Biogen TYSABRI Patents Spared Inter Partes Review Foley & Lardner LLP
Feb
27
2017
 Expansion of the Patent-Ineligibility Doctrine: Are Method of Treatment Claims Patent-Eligible? Foley & Lardner LLP
Jun
12
2017
 Supreme Court Decision Largely Favors Biosimilar Applicants Foley & Lardner LLP
Oct
10
2017
 Federal Circuit Questions Written Description For Antibody Claims Foley & Lardner LLP
Feb
19
2018
 Federal Circuit: Rare Guidance on Subject Matter Eligibility of Software Claims Foley & Lardner LLP
Feb
26
2018
 Board Rules that Tribal Immunity is Unavailable to Avoid Inter Partes Review Challenge Foley & Lardner LLP
May
15
2018
 Claim Construction Of An Enantiomeric Chemical Structure Foley & Lardner LLP
Aug
7
2018
 Sales Catalog From Dealer Trade Show Qualifies As Printed Publication Foley & Lardner LLP
Dec
4
2018
 PTAB SOP 1 Explains APJ Paneling Process Foley & Lardner LLP
Mar
11
2019
 New Guidance from Federal Circuit for Computer-Implemented Medical Methods Foley & Lardner LLP
Apr
23
2019
 Federal Circuit Scrutinizes Written Description In Provisional Application Foley & Lardner LLP
May
20
2019
 Federal Circuit Invalidates Patented Cancer Therapy Foley & Lardner LLP
Jul
9
2019
 Automotive Market Intelligence Foley & Lardner LLP
Oct
15
2019
 Federal Circuit Reverses PTAB On Reasonable Expectation Of Success For TARCEVA Patent Foley & Lardner LLP
Aug
17
2021
 Qualcomm Prevails at Federal Circuit Based on Lack of Notice and Adequate Opportunity to Respond Foley & Lardner LLP
Mar
2
2015
 Federal Circuit Upholds Patent Term Adjustment Deduction For IDS Filed After Restriction Requirement Foley & Lardner LLP
Apr
9
2015
 Apotex Has Standing Despite Benicar Patent Disclaimer Foley & Lardner LLP
Feb
23
2023
 Federal Circuit Weighs In On Patent Eligibility Of Isolated Vitamin Foley & Lardner LLP
Jun
9
2015
 Federal Circuit Finds Nunc Pro Tunc Agreement Does Not Confer Standing Foley & Lardner LLP
Sep
28
2015
 USPTO Won't Stop Kyle Bass Foley & Lardner LLP
Jan
7
2016
 Federal Circuit Backs PTAB Decision Curtailing A Party's Use Of "Supplemental" Information Foley & Lardner LLP
Jan
26
2016
 Incomplete Restriction Requirement Stops Clock For Patent Term Adjustment Foley & Lardner LLP
Apr
7
2016
 Guarding Against Conclusory Statements & Why It Matters Even More Under New PTAB Rules Foley & Lardner LLP
Aug
5
2016
 The Supreme Court to Tackle Extraterritorial Reach of U.S. Patents Foley & Lardner LLP
Oct
25
2016
 Decision To Grant Rehearing En Banc In Apple v. Samsung Foley & Lardner LLP
Feb
20
2017
 Federal Circuit Knocks Out Patents After CMB Challenge Foley & Lardner LLP
Feb
28
2017
 PTAB Puts Method Of Treatment Patents Under 101 Knife Foley & Lardner LLP
Jul
25
2017
 Federal Circuit Finds Velcade Patent Not Obvious Under Lead Compound Analysis Foley & Lardner LLP
Jan
23
2018
 Three Things To Know About Rule 130 Declarations Foley & Lardner LLP
Mar
15
2018
 USPTO Withdraws Newly Characterized Antigen Test For Written Description Of Antibodies Foley & Lardner LLP
Apr
24
2018
 Supreme Court Upholds the Constitutionality of Inter Partes Reviews Foley & Lardner LLP
May
8
2018
 USPTO Announces Notice of Proposed Rulemaking for Claim Construction Standard used in PTAB Proceedings Foley & Lardner LLP
Jun
5
2018
 Federal Circuit Finds Incorporation By Reference Inadequate For Priority Claim Foley & Lardner LLP
Oct
2
2018
 Blocking Patent Discounts Objective Indicia Of Non-Obviousness Foley & Lardner LLP
Nov
6
2018
 USPTO Addresses IDS PTA Deduction Error Foley & Lardner LLP
Mar
13
2019
 Court Dismisses Biosimilar Petitioner's IPR Appeal For Lack of Standing Foley & Lardner LLP
Mar
24
2020
 Federal Circuit Finds Eligibility In Non-Diagnostic Method Foley & Lardner LLP
Aug
17
2021
 Federal Circuit Finds No Assignment by Employment Agreement Foley & Lardner LLP
Mar
11
2015
 Federal Circuit Limits Patent Exhaustion Doctrine for Complementary Technology Foley & Lardner LLP
Jun
2
2015
 Another Sequenom Patent Appeal Heads To The Federal Circuit Foley & Lardner LLP
Jun
25
2015
 Federal Circuit Strikes Final Blow To Celebrex Patent Foley & Lardner LLP
Sep
8
2015
 Patent Trial and Appeal Board Boots Bass Tecfidera IPR On The Merits Foley & Lardner LLP
Sep
10
2015
 Clinical Trials As Prior Art: PTAB Denies Bass IPR Petition With Only A "Hope" of Efficacy Foley & Lardner LLP
Sep
28
2015
 PTAB Refuses To Sanction Kyle Bass Foley & Lardner LLP
Oct
6
2015
 Beware Reexamination Amendments Foley & Lardner LLP
Dec
2
2015
 Federal Circuit Denies Rehearing In Sequenom Foley & Lardner LLP
Jan
20
2016
 U.S. Supreme Court Accepts Appeal of First Inter Partes Review Decision: Could Mark Significant Turning Point in Claim Construction at PTAB Foley & Lardner LLP
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins